¾ÅÐãÖ±²¥

Is your research focused on health innovation? Do you want to see your research helping patients? If so, have you thought about factors and steps for successfully translating or commercializing your research?

Most researchers start thinking about translation/commercialization at the end of a research project, often when it is too late. Fortunately, the Market-focused Research workshop series, designed and delivered by Queen’s Partnerships and Innovation, will get you thinking about the steps involved in the translation/commercialization of your research at the beginning of a specific project so that outcomes are better aligned with target markets and the odds of successful translation/commercialization are improved.

Workshops will cover:

These workshops will equip early career researchers, post-doctoral fellows, and graduate students with the skills and knowledge, at the earliest stages of their research, to improve the translation/commercialization of their health innovations. Participants will learn skills and insights that will strengthen their grant applications, help to identify and build meaningful partnerships with industry and/or funding agencies, and create a greater awareness of Queen’s University and its research capabilities.

• Strategies for connecting and communicating with industry and the health-care sector so that you can make a critical assessment of your research/technology and validate the market opportunity through primary and secondary market research.
  November 5th, 9am-12pm
• Intellectual property (IP) and the role IP plays in the translation/commercialization of health-innovation research and how to conduct patentability and freedom-to-operate searches.
  November 12th, 9am-12pm
• Regulatory, quality, and clinical affairs including regulatory pathways (both Canada and US) for health innovations, quality requirements, design of pre-clinical studies and clinical trials.
  November 19th, 9am-12pm
• Commercialization strategies for health innovations including licensing and startup formation.
  November 26th, 9am-12pm

Participants who complete all four modules will receive a Certificate of Completion.

 Download the Market-Focused Research Workshop series flyer (PDF, 7 MB).

¾ÅÐãÖ±²¥ the speakers:

Dr. Michael Wells – Partnerships Development Officer, Queen’s Partnerships and Innovation

Michael completed his MBA at Queen’s University and his Ph.D. in the Faculty of Health Sciences at McMaster University. He has over 20 years’ experience in life science commercialization bridging early-stage company formation to country-level sales and marketing at a global pharmaceutical company, to his role in partnership development and technology transfer role at Queen’s.

Jason Hendry – Partnerships Development Officer, Queen’s Partnerships and Innovation

Jason has over 20 years’ experience in early-stage technology development and commercialization. He started his career with Millenium Biologix (now Octane Medical) where he led the development and commercialization of the company’s artificial bone technology, a class II medical device that was in clinical use in the US, Canada, and Europe. Since 2007, Jason has been working at Queen’s in technology transfer role, assessing the commercialization potential of technologies developed by Queen’s researchers, helping to secure intellectual property rights, and licensing those rights to industry partners, and more recently helping researchers to build partnerships.

Dr. Shoma Sinha – Partnerships Development Officer, Queen’s Partnerships and Innovation

With a PhD in nanotechnology and an MBA in innovation and entrepreneurship, Shoma is passionate about supporting partnership development, technology commercialization and the advanced technology ecosystem at large. Her experiences include: founding and growing non-profit organizations; developing and commercializing advanced materials technologies with startup/scaleup Quantiam Technologies; as well as supporting the growth of the provincial technology ecosystem with the Government of Alberta. As part of the later role, she developed and led a deep-tech accelerator program for recent advanced degree STEM graduates. Shoma joined Queen’s Partnerships and Innovation in February 2021.

Dr. Michael Jamieson – Advisory (Regulatory, Quality, and Translational Affairs), Queen’s Partnerships and Innovation

After spending twenty-five years in the pharmaceutical, biologics and medical device industries, Michael joined the Department of Regulatory and Quality Sciences at the University of Southern California in 2008 where he was the Associate Director of the International Center for Regulatory Science (ICRS) and an Assistant Professor. From 2019-2021, he was the Director for Clinical Translation at the Ottawa Hospital Research Institute. Michael recently joined the Queen’s Partnerships and Innovation team as an advisor providing regulatory/translational/quality support to Queen’s researchers and local companies.